Antiarrhythmic drugs work to regulate irregular heartbeats by affecting the electrical signaling and contraction of heart muscle. They are classified based on their mechanisms of action, such as blocking sodium, potassium, calcium, or beta-adrenergic channels. First generation drugs like quinidine block sodium channels, while later drugs prolong repolarization by blocking potassium channels or calcium influx. Precise dosing is important as antiarrhythmics can paradoxically cause dangerous arrhythmias. Pacemakers provide an alternative treatment by electrically stimulating the heart to maintain normal rhythm.
This presentation is about heart, it tells about how Cardiac muscles produce rhythmical beats, how the impulse are generated and conducted. This presentation tries to make Electrocardiogram easy to understand. Thank you
Diuretics
Pharmacology
Katzung
Abnormalities in fluid volume and electrolyte composition are common and important clinical disorders. Drugs that block specific transport functions of the renal tubules are valuable clinical tools in the treatment of these disorders. Although various agents that increase urine volume (diuretics) have been described since antiquity, it was not until 1937 that carbonic anhydrase inhibitors were first described and not until 1957 that a much more useful and powerful diuretic agent (chlorothiazide) became available. Technically, a “diuretic” is an agent that increases urine volume, whereas a “natriuretic” causes an increase in renal sodium excretion and an “aquaretic” increases excretion of solute-free water. Because natriuretics almost always also increase water excretion, they are usually called diuretics. Osmotic diuretics and antidiuretic hormone antagonists (see Agents That Alter Water Excretion) are aquaretics that are not directly natriuretic.
This presentation is about heart, it tells about how Cardiac muscles produce rhythmical beats, how the impulse are generated and conducted. This presentation tries to make Electrocardiogram easy to understand. Thank you
Diuretics
Pharmacology
Katzung
Abnormalities in fluid volume and electrolyte composition are common and important clinical disorders. Drugs that block specific transport functions of the renal tubules are valuable clinical tools in the treatment of these disorders. Although various agents that increase urine volume (diuretics) have been described since antiquity, it was not until 1937 that carbonic anhydrase inhibitors were first described and not until 1957 that a much more useful and powerful diuretic agent (chlorothiazide) became available. Technically, a “diuretic” is an agent that increases urine volume, whereas a “natriuretic” causes an increase in renal sodium excretion and an “aquaretic” increases excretion of solute-free water. Because natriuretics almost always also increase water excretion, they are usually called diuretics. Osmotic diuretics and antidiuretic hormone antagonists (see Agents That Alter Water Excretion) are aquaretics that are not directly natriuretic.
Individualized Webcam facilitated and e-Classroom USMLE Step 1 Tutorials with Dr. Cray. 1 BMS Unit is 4 hr. General Principles and some Organ System require multiple units to complete in preparation for the USMLE Step 1 A HIGH YIELD FOCUS IN Biochemistry / Cell Biology, Microbiology / Immunology and the 4 P’s-Phiso, Pathophys, Path and Pharm. Webcam Facilitated USMLE Step 2 Clinical Knowledge and Clinical Skills diadactic tutorials /1 Unit is 4 hours, individualized one-on-one and group sessions, Including all Internal Medicine sub-sub-specitialities. For questions or more information.. drcray@imhotepvirtualmedsch.com
This ppt is on the pharmacology of antiarrhythmic drugs,including description of mechanism of actions with diagrams showing different phases of action potentials...for easy grasping of principles...for medical students...
Definition of arrhythmia - background on cardiac physiology including conduction in heart - action potential - pathogensis of arrhythmia - causes and risk factors for arrhythmia- diagnosis of arrhythmia - symptoms of tachyarrhythmias and bradyarrhythmias - investigations for arrhythmia - treatment of arrhythmia - pharmacological and other modalities of therapy for arrhythmia - managment of different types of arrhythmias
Prepared by MD, PhD., Associate Professor, Marta R. Gerasymchyk, pathophysiology department of Ivano-Frankivsk National Medical University, Ukraine.
For medical students
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
2. BackgroundBackground
Recall: to function efficiently, heart needs to contractRecall: to function efficiently, heart needs to contract
sequentially (atria, then ventricles) and in synchronicitysequentially (atria, then ventricles) and in synchronicity
Relaxation must occur between contractions (not true forRelaxation must occur between contractions (not true for
other types of muscle [exhibit tetanyother types of muscle [exhibit tetany contract and holdcontract and hold
contraction for certain length of time])contraction for certain length of time])
Coordination of heartbeat is a result of a complex,Coordination of heartbeat is a result of a complex,
coordinated sequence of changes in membranecoordinated sequence of changes in membrane
potentials and electrical discharges in various heartpotentials and electrical discharges in various heart
tissuestissues
3. ArrhythmiaArrhythmia
Heart condition where disturbances inHeart condition where disturbances in
Pacemaker impulse formationPacemaker impulse formation
Contraction impulse conductionContraction impulse conduction
Combination of the twoCombination of the two
Results in rate and/or timing of contraction ofResults in rate and/or timing of contraction of
heart muscle that is insufficient to maintainheart muscle that is insufficient to maintain
normal cardiac output (CO)normal cardiac output (CO)
To understand how antiarrhythmic drugs work,To understand how antiarrhythmic drugs work,
need to understand electrophysiology ofneed to understand electrophysiology of
normal contraction of heartnormal contraction of heart
4. Normal heartbeat and atrial arrhythmiaNormal heartbeat and atrial arrhythmia
Normal rhythm Atrial arrhythmia
AV septum
5. Ventricular ArrhythmiaVentricular Arrhythmia
Ventricular arrhythmias areVentricular arrhythmias are
common in most people and arecommon in most people and are
usually not a problem but…usually not a problem but…
VA’s are most common cause ofVA’s are most common cause of
sudden deathsudden death
Majority of sudden death occurs inMajority of sudden death occurs in
people with neither a previouslypeople with neither a previously
known heart disease nor history ofknown heart disease nor history of
VA’sVA’s
Medications which decreaseMedications which decrease
incidence of VA’s do not decreaseincidence of VA’s do not decrease
(and may increase) the risk of(and may increase) the risk of
sudden deathsudden death treatment may betreatment may be
worse then the disease!worse then the disease!
6. Electrophysiology - resting potentialElectrophysiology - resting potential
A transmembrane electrical gradient (potential) isA transmembrane electrical gradient (potential) is
maintained, with the interior of the cell negative withmaintained, with the interior of the cell negative with
respect to outside the cellrespect to outside the cell
Caused by unequal distribution of ions inside vs. outsideCaused by unequal distribution of ions inside vs. outside
cellcell
NaNa++
higher outside than inside cellhigher outside than inside cell
CaCa++
much higher “ “ “ “much higher “ “ “ “
KK++
higher inside cell than outsidehigher inside cell than outside
Maintenance by ion selective channels, active pumpsMaintenance by ion selective channels, active pumps
and exchangersand exchangers
7. ECG (EKG) showing wave
segments
Contraction of
atria
Contraction of
ventricles
Repolarization of
ventricles
8. Cardiac Action PotentialCardiac Action Potential
Divided into five phases (0,1,2,3,4)Divided into five phases (0,1,2,3,4)
Phase 4Phase 4 - resting phase (resting membrane potential)- resting phase (resting membrane potential)
Phase cardiac cells remain in until stimulatedPhase cardiac cells remain in until stimulated
Associated with diastole portion of heart cycleAssociated with diastole portion of heart cycle
Addition of current into cardiac muscle (stimulation)Addition of current into cardiac muscle (stimulation)
causescauses
Phase 0Phase 0 – opening of fast Na channels and rapid depolarization– opening of fast Na channels and rapid depolarization
Drives NaDrives Na++
into cell (inward current), changing membrane potentialinto cell (inward current), changing membrane potential
Transient outward current due to movement of ClTransient outward current due to movement of Cl--
and Kand K++
Phase 1Phase 1 – initial rapid repolarization– initial rapid repolarization
Closure of the fast NaClosure of the fast Na++
channelschannels
Phase 0 and 1 together correspond to the R and S waves of thePhase 0 and 1 together correspond to the R and S waves of the
ECGECG
10. Cardiac Action Potential (con’t)Cardiac Action Potential (con’t)
Phase 2Phase 2 - plateau phase- plateau phase
sustained by the balance between the inward movement of Casustained by the balance between the inward movement of Ca++
andand
outward movement of Koutward movement of K ++
Has a long duration compared to other nerve and muscle tissueHas a long duration compared to other nerve and muscle tissue
Normally blocks any premature stimulator signals (other muscle tissueNormally blocks any premature stimulator signals (other muscle tissue
can accept additional stimulation and increase contractility in acan accept additional stimulation and increase contractility in a
summation effect)summation effect)
Corresponds to ST segment of the ECG.Corresponds to ST segment of the ECG.
Phase 3Phase 3 – repolarization– repolarization
KK++
channels remain open,channels remain open,
Allows KAllows K++
to build up outside the cell, causing the cell to repolarizeto build up outside the cell, causing the cell to repolarize
KK ++
channels finally close when membrane potential reaches certain levelchannels finally close when membrane potential reaches certain level
Corresponds to T wave on the ECGCorresponds to T wave on the ECG
11. Differences between nonpacemaker andDifferences between nonpacemaker and
pacemaker cell action potentialspacemaker cell action potentials
PCs - Slow, continuous depolarization during restPCs - Slow, continuous depolarization during rest
Continuously moves potential towards threshold for aContinuously moves potential towards threshold for a
new action potential (called a phase 4 depolarization)new action potential (called a phase 4 depolarization)
12. Mechanisms of Cardiac ArrhythmiasMechanisms of Cardiac Arrhythmias
Result from disorders of impulseResult from disorders of impulse
formation, conduction, or bothformation, conduction, or both
Causes of arrhythmiasCauses of arrhythmias
Cardiac ischemiaCardiac ischemia
Excessive discharge or sensitivity toExcessive discharge or sensitivity to
autonomic transmittersautonomic transmitters
Exposure to toxic substancesExposure to toxic substances
Unknown etiologyUnknown etiology
13. Disorders of impulse formationDisorders of impulse formation
No signal from the pacemaker siteNo signal from the pacemaker site
Development of an ectopic pacemakerDevelopment of an ectopic pacemaker
May arise from conduction cells (most are capable ofMay arise from conduction cells (most are capable of
spontaneous activity)spontaneous activity)
Usually under control of SA nodeUsually under control of SA node if it slows down too muchif it slows down too much
conduction cells could become dominantconduction cells could become dominant
Often a result of other injury (ischemia, hypoxia)Often a result of other injury (ischemia, hypoxia)
Development of oscillatory afterdepolariztionsDevelopment of oscillatory afterdepolariztions
Can initiate spontaneous activity in nonpacemaker tissueCan initiate spontaneous activity in nonpacemaker tissue
May be result of drugs (digitalis, norepinephrine) used to treatMay be result of drugs (digitalis, norepinephrine) used to treat
other cardiopathologiesother cardiopathologies
15. Disorders of impulse conductionDisorders of impulse conduction
May result inMay result in
Bradycardia (if have AV block)Bradycardia (if have AV block)
Tachycardia (if reentrant circuit occurs)Tachycardia (if reentrant circuit occurs)
Reentrant
circuit
16. Antiarrhythmic drugsAntiarrhythmic drugs
Biggest problem – antiarrhythmics canBiggest problem – antiarrhythmics can
cause arrhythmia!cause arrhythmia!
Example: Treatment of a non-life threateningExample: Treatment of a non-life threatening
tachycardia may cause fatal ventriculartachycardia may cause fatal ventricular
arrhythmiaarrhythmia
Must be vigilant in determining dosing, bloodMust be vigilant in determining dosing, blood
levels, and in follow-up when prescribinglevels, and in follow-up when prescribing
antiarrhythmicsantiarrhythmics
18. Classification of antiarrhythmicsClassification of antiarrhythmics
(based on mechanisms of action)(based on mechanisms of action)
Class I – blocker’s of fast NaClass I – blocker’s of fast Na++
channelschannels
Subclass IASubclass IA
Cause moderate Phase 0 depressionCause moderate Phase 0 depression
Prolong repolarizationProlong repolarization
Increased duration of action potentialIncreased duration of action potential
IncludesIncludes
QuinidineQuinidine – 1– 1stst
antiarrhythmic used, treat both atrial andantiarrhythmic used, treat both atrial and
ventricular arrhythmias, increases refractory periodventricular arrhythmias, increases refractory period
ProcainamideProcainamide - increases refractory period but side- increases refractory period but side
effectseffects
DisopyramideDisopyramide – extended duration of action, used only– extended duration of action, used only
for treating ventricular arrthymiasfor treating ventricular arrthymias
19. Classification of antiarrhythmicsClassification of antiarrhythmics
(based on mechanisms of action)(based on mechanisms of action)
Subclass IBSubclass IB
Weak Phase 0 depressionWeak Phase 0 depression
Shortened depolarizationShortened depolarization
Decreased action potential durationDecreased action potential duration
IncludesIncludes
LidocaneLidocane (also acts as local anesthetic) – blocks Na+(also acts as local anesthetic) – blocks Na+
channels mostly in ventricular cells, also good forchannels mostly in ventricular cells, also good for
digitalis-associated arrhythmiasdigitalis-associated arrhythmias
MexiletineMexiletine - oral lidocaine derivative, similar activity- oral lidocaine derivative, similar activity
PhenytoinPhenytoin – anticonvulsant that also works as– anticonvulsant that also works as
antiarrhythmic similar to lidocaneantiarrhythmic similar to lidocane
20. Classification of antiarrhythmicsClassification of antiarrhythmics
(based on mechanisms of action)(based on mechanisms of action)
Subclass ICSubclass IC
Strong Phase 0 depressionStrong Phase 0 depression
No effect of depolarizationNo effect of depolarization
No effect on action potential durationNo effect on action potential duration
IncludesIncludes
FlecainideFlecainide (initially developed as a local anesthetic)(initially developed as a local anesthetic)
Slows conduction in all parts of heart,Slows conduction in all parts of heart,
Also inhibits abnormal automaticityAlso inhibits abnormal automaticity
PropafenonePropafenone
Also slows conductionAlso slows conduction
WeakWeak ββ – blocker– blocker
Also some CaAlso some Ca2+2+
channel blockadechannel blockade
21. Classification of antiarrhythmicsClassification of antiarrhythmics
(based on mechanisms of action)(based on mechanisms of action)
Class II –Class II – ββ–adrenergic blockers–adrenergic blockers
Based on two major actionsBased on two major actions
1) blockade of myocardial1) blockade of myocardial ββ–adrenergic receptors–adrenergic receptors
2) Direct membrane-stabilizing effects related to Na2) Direct membrane-stabilizing effects related to Na++
channel blockadechannel blockade
IncludesIncludes
PropranololPropranolol
causes both myocardialcauses both myocardial ββ–adrenergic blockade and membrane-–adrenergic blockade and membrane-
stabilizing effectsstabilizing effects
Slows SA node and ectopic pacemakingSlows SA node and ectopic pacemaking
Can block arrhythmias induced by exercise or apprehensionCan block arrhythmias induced by exercise or apprehension
OtherOther ββ–adrenergic blockers have similar therapeutic effect–adrenergic blockers have similar therapeutic effect
MetoprololMetoprolol
NadololNadolol
AtenololAtenolol
AcebutololAcebutolol
PindololPindolol
StalolStalol
TimololTimolol
EsmololEsmolol
22. Classification of antiarrhythmicsClassification of antiarrhythmics
(based on mechanisms of action)(based on mechanisms of action)
Class III – KClass III – K++
channel blockerschannel blockers
Developed because some patients negativelyDeveloped because some patients negatively
sensitive to Na channel blockers (they died!)sensitive to Na channel blockers (they died!)
Cause delay in repolarization and prolongedCause delay in repolarization and prolonged
refractory periodrefractory period
IncludesIncludes
AmiodaroneAmiodarone – prolongs action potential by delaying K– prolongs action potential by delaying K++
effluxefflux
but many other effects characteristic of other classesbut many other effects characteristic of other classes
IbutilideIbutilide – slows inward movement of Na– slows inward movement of Na++
in addition toin addition to
delaying Kdelaying K ++
influx.influx.
BretyliumBretylium – first developed to treat hypertension but found to– first developed to treat hypertension but found to
also suppress ventricular fibrillation associated withalso suppress ventricular fibrillation associated with
myocardial infarctionmyocardial infarction
Dofetilide - prolongs action potential by delaying KDofetilide - prolongs action potential by delaying K++
efflux withefflux with
no other effectsno other effects
23. Classification of antiarrhythmicsClassification of antiarrhythmics
(based on mechanisms of action)(based on mechanisms of action)
Class IV – CaClass IV – Ca2+2+
channel blockerschannel blockers
slow rate of AV-conduction in patients withslow rate of AV-conduction in patients with
atrial fibrillationatrial fibrillation
IncludesIncludes
Verapamil – blocks NaVerapamil – blocks Na++
channels in addition to Cachannels in addition to Ca2+;2+;
also slows SA node in tachycardiaalso slows SA node in tachycardia
DiltiazemDiltiazem
24. PacemakersPacemakers
Surgical implantation of electrical leads attached to aSurgical implantation of electrical leads attached to a
pulse generatorpulse generator
Over 175,000 implanted per yearOver 175,000 implanted per year
1)1) Leads are inserted via subclavicle vein and advanced to theLeads are inserted via subclavicle vein and advanced to the
chambers on the vena cava (right) side of the heartchambers on the vena cava (right) side of the heart
2)2) Two leads used, one for right atrium, other for right ventricleTwo leads used, one for right atrium, other for right ventricle
3)3) Pulse generator containing microcircuitry and battery arePulse generator containing microcircuitry and battery are
attached to leads and placed into a “pocket” under the skinattached to leads and placed into a “pocket” under the skin
near the claviclenear the clavicle
4)4) Pulse generator sends signal down leads in programmedPulse generator sends signal down leads in programmed
sequence to contract atria, then ventriclessequence to contract atria, then ventricles
Pulse generator can sense electrical activity generatedPulse generator can sense electrical activity generated
by the heart and only deliver electrical impulses whenby the heart and only deliver electrical impulses when
needed.needed.
Pacemakers can only speed up a heart experiencingPacemakers can only speed up a heart experiencing
bradycardia, they cannot alter a condition ofbradycardia, they cannot alter a condition of
tachycardiatachycardia